Code is covered without prior authorization (high confidence)
Key Coverage Criteria
The use of DMEK, DSEK, DSAEK and DMAEK, is consideredmedically necessaryfor the treatment of disorders of the corneal endothelium, including but not limited to the following:
Fuchs’ endothelial dystrophy;
Aphakic and pseudophakic bullous keratopathy (corneal edema following cataract extraction);
Failure or rejection of a previous corneal transplant.